A rare class of disorders called myelodysplastic syndrome prevents the body from producing healthy blood cells. It is also referred to as “bone marrow failure.” Although it affects people of any age, this rare type of cancer primarily affects the elderly, particularly those over 65. A blood test is usually used to detect or diagnose this condition. The symptoms are fatigue and shortness of breath. Some of the treatments for this condition are listed below.

Treatment options for myelodysplastic syndromes
The primary goals of myelodysplastic syndrome treatment are to reduce the illness’ progression, ameliorate its symptoms, and avoid complications. Since this condition has no known cure, certain treatments may limit its progression.

Transfusion therapy
Transfusion therapy (blood transfusion) replaces blood cells destroyed by illness or treatment by infusing red blood cells, white blood cells, or platelets. A red blood cell transfusion is administered when the blood cell count is low and signs of anemia, such as shortness of breath or fatigue, occur.
A platelet transfusion is frequently given to a patient undergoing a procedure that may result in bleeding or a low platelet count. Besides, patients who frequently receive blood transfusions may suffer tissue and organ damage from excess iron accumulation. These patients may receive iron chelation therapy to eliminate the excess iron from the blood.

Chemotherapy
Chemotherapy is a method of eliminating damaged cells by preventing them from dividing and growing. A chemotherapy schedule, or regimen, typically consists of a set number of rounds administered over a set period. Conventional chemotherapy may help people with high-risk MDS subtypes. Depending on the patient and the dosage used, this type of therapy may cause fatigue, an increased risk of infection, nausea and vomiting, hair loss, a loss of appetite, and diarrhea. When the treatment is over, these side effects usually disappear.

Immunotherapy
Immunotherapy, sometimes called “biologic therapy,” improves the body’s built-in defenses against MDS. It uses chemicals produced naturally by the body or chemically in a lab to enhance, target, or restore immune system function. Although not widely employed in MDS patients, this may still be an option for some. Immunotherapy can have several negative side effects.